Global Biological API Drug Manufacturing Market

Global Biological API Drug Manufacturing Market Research Report 2021

Global Biological API Drug Manufacturing Market

Global Biological API Drug Manufacturing Market Research Report 2021


Analysis of the Biological API Drug Manufacturing Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Biological API Drug Manufacturing Market Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Biological API Drug Manufacturing Market Market Overview:

Global Biological API Drug Manufacturing Market Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Biological API Drug Manufacturing Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Biological API Drug Manufacturing Market Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Biological API Drug Manufacturing Market market in 2020.

Global Biological API Drug Manufacturing Market Market Segmentation

By Type, Biological API Drug Manufacturing Market market has been segmented into:

In-House manufacturing

Contract manufacturing

By Application, Biological API Drug Manufacturing Market market has been segmented into:

Monoclonal Antibody (mAb) Therapies

Vaccines

Insulin Therapies

Interferon Therapies

Others

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Biological API Drug Manufacturing Market market are:

Lonza

Boehringer Ingelheim BioXcellence

Celltrion

DSM

Samsung BioLogics

Fujifilm Diosynth Biotechnologies

Cytovance Biologics

AbbVie

Baxter

CEPiA Sanofi

GSK

Pfizer CentreOne

Sandoz

Vetter

Wuxi Biologics

1. Market Overview of Biological API Drug Manufacturing Market

1.1 Biological API Drug Manufacturing Market Market Overview

1.1.1 Biological API Drug Manufacturing Market Product Scope

1.1.2 Market Status and Outlook

1.2 Biological API Drug Manufacturing Market Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Biological API Drug Manufacturing Market Historic Market Size by Regions (2015-2020)

1.4 Biological API Drug Manufacturing Market Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Biological API Drug Manufacturing Market Sales Market by Type (2015-2026)

2.1 Global Biological API Drug Manufacturing Market Historic Market Size by Type (2015-2020)

2.2 Global Biological API Drug Manufacturing Market Forecasted Market Size by Type (2021-2026)

2.3 In-House manufacturing

2.4 Contract manufacturing

3. Covid-19 Impact Biological API Drug Manufacturing Market Sales Market by Application (2015-2026)

3.1 Global Biological API Drug Manufacturing Market Historic Market Size by Application (2015-2020)

3.2 Global Biological API Drug Manufacturing Market Forecasted Market Size by Application (2021-2026)

3.3 Monoclonal Antibody (mAb) Therapies

3.4 Vaccines

3.5 Insulin Therapies

3.6 Interferon Therapies

3.7 Others

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Biological API Drug Manufacturing Market Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Biological API Drug Manufacturing Market Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Biological API Drug Manufacturing Market Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Biological API Drug Manufacturing Market Business

5.1 Lonza

5.1.1 Lonza Company Profile

5.1.2 Lonza Biological API Drug Manufacturing Market Product Specification

5.1.3 Lonza Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Boehringer Ingelheim BioXcellence

5.2.1 Boehringer Ingelheim BioXcellence Company Profile

5.2.2 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Market Product Specification

5.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 Celltrion

5.3.1 Celltrion Company Profile

5.3.2 Celltrion Biological API Drug Manufacturing Market Product Specification

5.3.3 Celltrion Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 DSM

5.4.1 DSM Company Profile

5.4.2 DSM Biological API Drug Manufacturing Market Product Specification

5.4.3 DSM Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Samsung BioLogics

5.5.1 Samsung BioLogics Company Profile

5.5.2 Samsung BioLogics Biological API Drug Manufacturing Market Product Specification

5.5.3 Samsung BioLogics Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Fujifilm Diosynth Biotechnologies

5.6.1 Fujifilm Diosynth Biotechnologies Company Profile

5.6.2 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Market Product Specification

5.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Cytovance Biologics

5.7.1 Cytovance Biologics Company Profile

5.7.2 Cytovance Biologics Biological API Drug Manufacturing Market Product Specification

5.7.3 Cytovance Biologics Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 AbbVie

5.8.1 AbbVie Company Profile

5.8.2 AbbVie Biological API Drug Manufacturing Market Product Specification

5.8.3 AbbVie Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 Baxter

5.9.1 Baxter Company Profile

5.9.2 Baxter Biological API Drug Manufacturing Market Product Specification

5.9.3 Baxter Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 CEPiA Sanofi

5.10.1 CEPiA Sanofi Company Profile

5.10.2 CEPiA Sanofi Biological API Drug Manufacturing Market Product Specification

5.10.3 CEPiA Sanofi Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 GSK

5.11.1 GSK Company Profile

5.11.2 GSK Biological API Drug Manufacturing Market Product Specification

5.11.3 GSK Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 Pfizer CentreOne

5.12.1 Pfizer CentreOne Company Profile

5.12.2 Pfizer CentreOne Biological API Drug Manufacturing Market Product Specification

5.12.3 Pfizer CentreOne Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 Sandoz

5.13.1 Sandoz Company Profile

5.13.2 Sandoz Biological API Drug Manufacturing Market Product Specification

5.13.3 Sandoz Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.14 Vetter

5.14.1 Vetter Company Profile

5.14.2 Vetter Biological API Drug Manufacturing Market Product Specification

5.14.3 Vetter Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.15 Wuxi Biologics

5.15.1 Wuxi Biologics Company Profile

5.15.2 Wuxi Biologics Biological API Drug Manufacturing Market Product Specification

5.15.3 Wuxi Biologics Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Biological API Drug Manufacturing Market Market Size (2015-2026)

6.2 North America Biological API Drug Manufacturing Market Key Players in North America (2015-2020)

6.3 North America Biological API Drug Manufacturing Market Market Size by Type (2015-2020)

6.4 North America Biological API Drug Manufacturing Market Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Biological API Drug Manufacturing Market Market Size (2015-2026)

7.2 East Asia Biological API Drug Manufacturing Market Key Players in North America (2015-2020)

7.3 East Asia Biological API Drug Manufacturing Market Market Size by Type (2015-2020)

7.4 East Asia Biological API Drug Manufacturing Market Market Size by Application (2015-2020)

8. Europe

8.1 Europe Biological API Drug Manufacturing Market Market Size (2015-2026)

8.2 Europe Biological API Drug Manufacturing Market Key Players in North America (2015-2020)

8.3 Europe Biological API Drug Manufacturing Market Market Size by Type (2015-2020)

8.4 Europe Biological API Drug Manufacturing Market Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Biological API Drug Manufacturing Market Market Size (2015-2026)

9.2 South Asia Biological API Drug Manufacturing Market Key Players in North America (2015-2020)

9.3 South Asia Biological API Drug Manufacturing Market Market Size by Type (2015-2020)

9.4 South Asia Biological API Drug Manufacturing Market Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Biological API Drug Manufacturing Market Market Size (2015-2026)

10.2 Southeast Asia Biological API Drug Manufacturing Market Key Players in North America (2015-2020)

10.3 Southeast Asia Biological API Drug Manufacturing Market Market Size by Type (2015-2020)

10.4 Southeast Asia Biological API Drug Manufacturing Market Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Biological API Drug Manufacturing Market Market Size (2015-2026)

11.2 Middle East Biological API Drug Manufacturing Market Key Players in North America (2015-2020)

11.3 Middle East Biological API Drug Manufacturing Market Market Size by Type (2015-2020)

11.4 Middle East Biological API Drug Manufacturing Market Market Size by Application (2015-2020)

12. Africa

12.1 Africa Biological API Drug Manufacturing Market Market Size (2015-2026)

12.2 Africa Biological API Drug Manufacturing Market Key Players in North America (2015-2020)

12.3 Africa Biological API Drug Manufacturing Market Market Size by Type (2015-2020)

12.4 Africa Biological API Drug Manufacturing Market Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Biological API Drug Manufacturing Market Market Size (2015-2026)

13.2 Oceania Biological API Drug Manufacturing Market Key Players in North America (2015-2020)

13.3 Oceania Biological API Drug Manufacturing Market Market Size by Type (2015-2020)

13.4 Oceania Biological API Drug Manufacturing Market Market Size by Application (2015-2020)

14. South America

14.1 South America Biological API Drug Manufacturing Market Market Size (2015-2026)

14.2 South America Biological API Drug Manufacturing Market Key Players in North America (2015-2020)

14.3 South America Biological API Drug Manufacturing Market Market Size by Type (2015-2020)

14.4 South America Biological API Drug Manufacturing Market Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Biological API Drug Manufacturing Market Market Size (2015-2026)

15.2 Rest of the World Biological API Drug Manufacturing Market Key Players in North America (2015-2020)

15.3 Rest of the World Biological API Drug Manufacturing Market Market Size by Type (2015-2020)

15.4 Rest of the World Biological API Drug Manufacturing Market Market Size by Application (2015-2020)

16 Biological API Drug Manufacturing Market Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Biological API Drug Manufacturing Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Biological API Drug Manufacturing Market?
Some of the finest and top-notch companies pioneering the Biological API Drug Manufacturing Market are Lonza, Boehringer Ingelheim BioXcellence, Celltrion, DSM, Samsung BioLogics, Fujifilm Diosynth Biotechnologies, Cytovance Biologics, AbbVie, Baxter, CEPiA Sanofi, GSK, Pfizer CentreOne, Sandoz, Vetter, Wuxi Biologics.
How is the competition changing gears in the Biological API Drug Manufacturing Industry?
Emerging markets will create new demands and put pressure on the industry to act quickly. Simultaneously, market players such as Lonza, Boehringer Ingelheim BioXcellence, Celltrion, DSM, Samsung BioLogics, Fujifilm Diosynth Biotechnologies, Cytovance Biologics, AbbVie, Baxter, CEPiA Sanofi, GSK, Pfizer CentreOne, Sandoz, Vetter, Wuxi Biologics will face challenges from the industry's increasing pace of consolidation, particularly in North America and Europe.
Who are the significant end-users in the Biological API Drug Manufacturing Market?
The key end-users in the Biological API Drug Manufacturing Market are Market, Monoclonal Antibody (mAb) Therapies, Vaccines, Insulin Therapies, Interferon Therapies, Others
What is the market value of the Biological API Drug Manufacturing Industry?
In 2024, the Biological API Drug Manufacturing Market share exceeded USD xx million. Between 2025 and 2030, it will grow at a CAGR of yy%.
What challenges does the Biological API Drug Manufacturing Market face in the future?
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Biological API Drug Manufacturing Market across the extensive corporate landscape.
What is the estimated global market value of the Biological API Drug Manufacturing Market?
The Biological API Drug Manufacturing Market is expected to reach a considerable market valuation.